Production of thrombolytic kinase (natto kinase) and its use
A technology of thrombokinase and thrombolysis, which is applied in the field of microorganisms, can solve the problems of complicated operation steps and complex extraction process of thrombolytic kinase, achieve obvious thrombolytic effect, enhance the effect of thrombosis prevention and treatment, and increase the production rate
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
example 1
[0031] Example 1 Production of Thrombolytic Kinase
[0032] After the Bacillus subtilis slant strain is activated, it is connected to the shake flask seed medium, cultivated at a constant temperature of 32 to 38°C at 150 to 250 rpm for 24 hours, and then connected to the fermentation medium, and the fermenter is fermented for 42 to 45 hours and then out of the tank. The average enzyme activity reaches 2100IU, pre-cooled to about 10°C, pumped into a two-stage microfiltration machine to collect the filtrate, and the enzyme activity yield is over 90%; The hollow fiber ultrafiltration concentration reaches more than 20 times, and the enzyme activity yield is more than 80%; the thrombolytic kinase concentrate is added with auxiliary materials and freeze-dried to obtain a solid powder with an enzyme activity of more than 20,000 IU / g.
example 2
[0033]Example 2 Thrombolytic Kinase Application (Taking the Capsule Finished Product as Example)
[0034] The thrombolytic kinase activity (equivalent to urokinase) produced by this technical scheme reaches more than 20,000 IU grams. Take 5,000 IU a day, take 2 times a day, and take 1 capsule each time. It can be directly loaded into enteric-coated capsules, and the capacity is adjusted by isomaltooligosaccharides. Each capsule contains 0.25 grams.
[0035] 1 gram of thrombolytic kinase (calculated at 20,000 IU / gram) freeze-dried powder, combined with 8 mg of functional auxiliary materials folic acid, 400 mg of Vc, VB 12 12 mg, 1 g of soybean lecithin, mix well, pack into 8 enteric-coated capsules.
[0036] The above-mentioned products, as health care products for people prone to cardiovascular and cerebrovascular diseases, are used for the prevention or auxiliary treatment of thrombotic cardiovascular and cerebrovascular diseases.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com